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ABSTRACT
Synthetic, spectroscopic and antimicrobial aspects of some fertility inhibitor heterobimetallic
complexes have been carried out. These heterobimetallic chelates [M(CsHsN3)EM2’(R)4]C12 (M Pd or Pt
and M’= Si, Sn, Ti and Zr) have been successfully synthesized via the reaction ofM(CsH7N3)CI with group
four or fourteen dichlorides in 1:2 stoichiometric proportions. The products were characterized by elemental
analyses, molecular weight determinations, magnetic susceptibility measurements, conductance, and IR,
multinuclear NMR and electronic spectral studies. A square planar geometry has been suggested for all the
complexes with the help of spectral data. Conductivity data strongly suggest that chlorine atoms are ionic in
nature due to which complexes behave as electrolytes. All the complexes have been evaluated for their
antmicrobial effects on different species of pathogenic fungi and bacteria. The testicular sperm density,
testicular sperm morphology, sperm motility, density of cauda epididymal spermatozoa and fertility in
mating trails and biochemical parameters of reproductive organs have been examined and discussed.
INTRODUCTION
The complexes of metal ions with macrocyclic ligands are significant because of their resemblance
with many natural systems, such as porphyrins and cobalamines2. Many of the transition metal ions in the
living systems work as enzymes or carriers in macrocyclic ligand field environment. Therefore, meaningful
research in this direction might generate simple models for biologically occurring metallo enzymes and thus
will help in developing our understanding of biological systems. These ligands are also of theoretical interest
as they are capable of furnishing an environment of controlled geometry and ligand field strength4"7. A
literature survey disclosed that a number of polydentate macrocyclic ligands and their metal complexes have
been reported8. Their electronic properties and reactivities are ressemble those of porphyrins.
On the other hand, the discovery of cisplatin, an important cytotoxic drug used in the treatment of a
variety of human cancer, has given a new dimention to the coordination chemistry of platinum and
palladium. It may be possible that useful anticancer drugs might be found among palladium complexes. A
wealth of data has been accumulated in the search of novel potent antitumor agents. Transition metal chelates
of nitrogen donor ligands have been extensively screened for their antitumor activity. Most of them showed
some activity but significant activities were exhibited by palladium and platinum complexes. In principle,
coordination compounds offer a great variety of shapes and reactivities for use in drug design, the most
detailed advances have been in understanding how cis-DDP binds to DNA. A clear knowledge of how
platinum antitumor drugs work would have major implications for the further design and improvement of
these inorganic drugs. The use of metal as template in condensation reactions has led to the synthesis of a
large number of metal complexes of macrocyclic ligands. Macrocyclic ligands are relatively rigid and thus
impose a specific coordination geometry on the metal ion9. Macrocyclic ligands display a number of
chemical interesting features which include unusual structures. The occurrence of metal exchange
(transmetallation) reactions is used for the preparation of new metal complexes not accessible by direct
synthetic procedure
A wider range of organosilicon compounds is being studied due to their importance in resin and
liquid polymer Chemistry1’3 Well known exemplary series of di and triorganotin halides with various
nitrogen and oxygen/sulphur containing ligands have been found to possess significant biological and
pharmacological activities. Screening data for tin derivatives
16,17 have revealed that many more diorganotin
compounds exhibit antitumour activity than the corresponding mono-,tri-,and tetra-organotins or the
inorganic tin chemicals, while within the diorganotin class, the highest activity was given by the diethyl tin
derivatives8. Similarly, some of the organotin have been evaluated as potential mosquito larvicides 19.
Transition metal complexes of nitrogen donor ligands have been studied in detail on account of their
20 21 interesting stereochemistry and wide practical utility. Transition metals and their complexes have evolved
great interest due to their biological potential22’2 unusual structural aspects, unique stereo and magneto
chemistry
24 and ability to form multiple complexes.
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Several reports have appeared on multimetallic complexes
25 associated with electrochemical,
magnetic and spectroscopic studies and their stable complexes which are of biological interest but studies on
the heterobimetallic complexes of palladium and platinum seem to be comparatively limited. Therefore, in
view of the above facts it was considered as useful to synthesize such a type of compounds with an aim to
characterize them structurally, electrochemically and biologically.
MATERIALS AND METHODS
All the chemicals and solvents used were dried and purified by standard methods. The reactions
were carried out under strictly anhydrous conditions.
Preparation of M(C5H7N3)CI2
The solution of MCI2 (1 mmol) was mixed with the methanolic solution of 2,6 diaminopyridine
(2 mmol). The reaction mixture was stirred for 6-7 hours. The resulting precipitate was recovered by
filteration washed with methanol and dried in vacuo. The reactions proceed as: MCI2 + 2CsH7N3-
M(CsH7N3)2CI2.
Preparation of Heterobimetallic Complexes
Heterobimetallic complexes were synthesized by stirring a methanolic solution of M(CsH7N3)2CI2
with methanolic solution of group four or fourteen metal dichlorides CpEM’CI2, Ph2MCI2 and MeEMCI2. The
reaction mixture was kept at room temperature for overnight and stirred for 6-7 hours to complete the
reaction. The coloured solid compound separated out. The excess of the solvent was removed under reduced
pressure and the complexes were dried for 3-4 hours in vacuo. The complexes were purified by
crystallization. The yield was 60-70%. The analytical and physical data of the isolated precursor and their
complexes are given in Table I.
Table I: Physical Properties and Analytical Data of Complexes
Complex
Pd(CsH7N3) 2C12
Pd(CsHsN3)2CI2Sn2(CH3)4
Pd(CsHN3)zCI2Sn2(C6Hs)4
Pd(CsHsN3)zCIzSi2(CH3)4
Pd(CsHsN3)2CI2Si2(C6Hs) 4
Pd(C5HN3)2CI2Ti2(C5 H5)4
Pd(CsHsN3)zCI2Zr2(C5 H5)4
Pt(CsH7N3)2CI2
Pt(CsHsN3)2CI2Sn2(CH3)4
Pt(C5HsN3)2CI2Sn2(C6Hs)4
Pt(CsHN )2C 12S i2(CH )4
Pt(csHsN3)2CI2Si2(C6H5) 4
Pt(CsH5N3)2CI2Ti2(C5 Hs) 4
Pt(CsHsN3)2CI2Zr2(C5 Hs) 4
Analysis(%)
Colour M.P. (C) M Pt/Pd N C! Mol.Wt.
Found Found Found Found Found
(Calcd) (Calcd) (Calcd) (Calcd) (Calcd)
Light 110 (d) 26.90 21.24 17.92 395.56
Brown (26.88) (21.21) (17.90) (371.69)
Orange 101 15.44 34.45 12.19 10.28 689.02
(15.42) (34.43) (12.14) (10.25) (680.00)
Reddish 126 11.35 25.32 8.96 7.56 937.32
Brown (11.32) (25.30) (8.93) (7.54) (922.34)
Dark 174 20.94 11.05 16.54 13.96 507.80
Brown (20.93) (11.03) (16.52) (13.93) (489.84)
Red 152 (d) 14.07 14.85 11.11 9.37 756.06
(14.04) (14.82) (11.09) (9.35) (734.87)
Light >300 14.23 12.80 11.24 9.48 747.66
Brown (14.00) (12.78) (11.21) (9.45) (723.78)
Dark 120 12.75 21.86 10.07 8.49 834.34
Green (12.73) (21.83) (10.04) (8.47) (829.38)
Grey 165 40.28 17.35 14.64 484.22
(40.26) (17.32) (14.62) (477.20)
Light 141 25.08 30.52 10.80 4.55 777.68
Green (25.06) (30.49) (10.77) (4.52) (757.79)
Light 139 19.01 23.13 8.19 3.45 1025.98
Green (18.98) (23.10) (8.17) (3.42) (1002.89)
Light 120 32.70 9.41 14.08 11.88 596.46
Green (32.68) (9.39) (14.05) (11.86) (579.41
Grey 90 23.09 6.65 9.94 8.39 844.76
(23.07) (6.63) (9.91) (8.37) (829.43)
Brown 136 23.32 11.45 10.04 8.47 836.32
(23.30) (11.42) (10.01 (8.44) (814.48)
Dark 146 (d) 21.13 19.76 9.10 7.68 923.00
Green (21.11) (19.73) (9.07) (7.66) (904.04)
Analytical Methods and Physical Measurements
Conductivity measurements were made with a systronics model 305 conductivity bridge. The molecular
weights were determined by the Rast camphor method. Infra red spectra of precursors and complexes were
recorded in the range 4000-200 cm with the help ofNicolet-Megna FT-IR 550 spectrophotometer in KBr pellets.
Electronic spectra were recorded on a Varian Cary/2390 spectrophotometer. H NMR and metal NMR spectra
were recorded in DMSO-d6 versus TMS as standard on a JEOL FX-90Q spectrometer. Magnetic measurements
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of powdered samples at the room temperature were recorded on a vibrating sample magnetometer Model 155 at
the RSIC, IIT, Madras. Platinum, titanum, zirconium, tin and silicon were estimated gravimetrically as their
oxides. Nitrogen was estimated by Kjeldahl’s method, and chlorine by Volhard’s method.
RESULTS AND DISCUSSION
The elemental analysis and spectral data are consistent with the formulations of the compounds as
M(CsH7N3)2CI2 and [M(CsHsN3)2M’2(R)4]. The reactions of MCI2 with CH7N3 have been carried out in 1:2 molar
ratios in methanol to yield M(CsHTN3) 2C12. This complex reacts with group four or fourteen metal dichloride to yield
heterobimetallic chelates [M(CHN3)2M’2(R)4].
The reactions proceed easily at room temperature. The coloured solid products so obtained are
soluble in DMF and DMSO. The complexes are monomeric in camphor as indicated by the molecular weight
determinations. Magnetic measurements showed them to be diamagnetic. However, the complexes are 1:2
electrolytes in DMSO as indicated by their molar conductance values (200-225 ohm
"l cm mol).
SPECTRAL STUDIES
IR Spectra
The IR spectra of bimetallic complexes compare well the spectra of M(CsHTN3)2Cle. The primary
stretch is located at higher frequency than that of the corresponding secondary amine26. The spectra of
M(CsH7N3)eCI2 exhibit a broad and strong band in the range 3280- 3140 cm" assigned to v(N-H). This band is found
at lower frequency (3098 cm)
27 in the complex. This may be taken as an evidence for the coordination of secondary
nitrogen to metal. Aromatic ring stretching (c---c)
28 are present at 1646, 1520 and 1468 cm". The presence of
aromatic C-H and C-N bonds in the complex have been confirmed by the appearance of two bands at 3055
and 846 cm, respectively.
The coordination of nitrogen to the metal is further supported by the appearance ofnew bands ofmedium
to weak intensity in the regions 581 cm
"1 and 410 cm
"1 attributable to (Si <---N)
29 and ag(Sn <--N) vibrations,
respec3tvely. Apart from this, the band at 447 cm
"l and 442 cm" ma2aY be assignedaatO v(Ti-CsHs)
3 and a3 (Zr-
C5H5) vibrations. The bands at ca 520-550 cm are due to a(Ti-N) and v(Zr-N) bonds.
H NMR Spe.tra
The H NMR spectra of the precursors and their complexes have been recorded in DMSO-d6 using
TMS as an internal standard. The disappearance of the amine proton signal and the appearance of a secondary
amine proton signal in case of bimetallic complexes indicated the deprotonation of the NHz group after
complexation. Chemical shift values of all the compounds are listed in Table II.
Table II: HNMR Spectral Data (5, ppm) of Precursors and Their Corresponding Complexes
Compound -NH2 -NH -R -Ph
Pd(CsH7N3)2CI2 4.58
Pd(CsHsN3)2CI2Sn2 (CH3)4
Pd(CsHsN3)2CI2Sn2(C6Hs)4
Pd(CsHNs)2CIzSi2(CH3) 4
Pd(CsHN3)2CI2Si2(C6Hs)4
Pd(CsHsN)2CI2Ti2(CHs)4
Pd(CHN3)2CI2Zr2(CsH)4
Pt(CsHTN3)2CI 4.56
Pt(CHN3)zCI2Sn2(CH3)4
Pt(CHsN3)2CI2Sn2(C6Hs)4
Pt(CHN3)2CI2Si2(CH3)4
Pt(CHsN3)2CI2S i2(C6H5)4
Pt(CHN3)2CI2Ti2(CH5)4
Pt(CHN3).CI2Zrz(CHs)4
l9Sn, 29Si and 9Spt NMR Spectra
7.26-7.38
8.02 1.53 7.31-7.56
8.08 7.22-7.34 7.22-7.34
8.13 1.67 7.04-7.51
7.89 7.12-7.63 7.12-7.63
7.84 6.19 7.09-7.13
8.00 6.33 7.03-7.17
7.09-7.23
7.98 1.28 7.01-7.21
8.04 7.09-7.37 7.09-7.37
1.37 7.04-7.19
8.02 7.04-7.35 7.04-7.35
8.00 6.51 7.06-7.15
7.93 6.42 7.00-7.29
The four coordination number of tin in these complexes were further get support by the appearance
of sharp signals at -31.23ppm in ll9SnNMR spectra34.
In the cases of the silicon complexes, signals appeared at 5-50.99ppm are assigned for tetra coordinated
state
35 around the silicon atom.
195pt spectra show signals at 5-2721ppm, indicative to tetra coordinated state
36 of complexes.
3C NMR Spectra
In the 3C NMR spectra of the precursors and their complexes, considerable shifts in the position of
carbon atoms adjacent to atoms involved in complex formation clearly indicate the bonding of metal to the
imino nitrogen atoms. Spectral data are given in Table Ill.
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Table III: 3C NMR Spectral Data (&ppm) of Precursors and Their Corresponding Complexes.
Compound C-M’ C-N C3 C4 R
Pd(CsH7N3)2CI2
Pd(CsHsN3)2CI2Sn2 (CH3)4 17.6
Pd(CsHsN3)2CI2Sn2(C6Hs)4 129.18
Pd(CsHsN3)2CI2Si2(CH3) 4
Pd(CsHsN3)2CI2Si2(C6H5)4
Pd(CsHsN3)zCI2Ti2(CsHs)4
Pd(CsHsN3)2CI2Zr2(CsHs)4
Pt(CsH7N3)2C12
Pt(CsHsNa)CI2Sn(CH3)4
Pt(CsHsN3)2CI2Sn2(C6Hs)4
Pt(CsHsN3)2CI2Si2(CH3)4
Pt(CsHsN3)2C12Si2(C6H5)4
Pt(CsHsN3)2CI2Ti2(CsHs)4
Pt(CHsN3)2CI2Zr2(CH)4
146.77 142.17 139.73
155.31 150.89 146.63
160.21 157381 153.62 127.15(C2",C6"), 125.93(C3",C5"),
124.58(C4")
14.51 138.51 131.73 127.61
134.62 152.30 150.83 141.98 132.60 (C2",C6"), 130.21 (C3",C5")
127.19 (C4")
113.01 149.48 147.92 144.49 111.13 (C2’, C’),101.98 (C3’,C4’)
108.96 143.81 140.98 138.82 107.41 (C2’,C’) 106.01 (C3’,C4’)
148.23 142.39 136.72
17.9 158.24 152.38 150.21
132.92 163.11 160.02 157.77 130.83(C2",C6"),128.81 (C3" C6")
127.91 (C4")
14.54 135.21 132.61 129.43
136.83 153.39 151.30 146.83 134.98 (C2",C6"), 131.76(C3",C5),
130.84 (C4")
112.81 148.41 142.53 138.91 111.16 (C2’,C’), 108.81 (C3’,C4’)
109.74 144.12 140.09 138.82 108.81 (C2’,C’), 106.93 (C3’,C4’)
Electronic Spectra
The formation of heterobimetallic complexes is further supported by the electronic spectra.
Palladium (II) and platinum(II) complexes display d-d spin-allowed transitions due to three lower lying ’d’
levels to the empty dx2.y2 orbitals. Transitions are located from ground state 1Alg to the exited states rA2,
lBlg and lEg in order of increasing energy. Three d-d bands are assigned in the ranges 535 560nm, 455-
475nm and 440 -451nm in the palladium complexes and 519- 530nm, 440- 465nm and 339- 376nm in the
case of platinum complexes. These bands are attributed to 1Alg )lAEg, 1Alg-- 1Big and 1Alg--) lEg
transitions, respectively. These spectral values support the square planar geometry (Fig.l) around Pd(II) and
Pt(II) and are in agreement with those reported earlier for square planar complexesav.
BIOLOGICAL STUDIES
Such complexes have served as models for a number of biochemical process. Therefore, all the
complexes of palladium and platinum along with the precursors have been tested on various fungi and
bacteria.
Table IV: Fungicidal Screening Data of Precursors and Their Heterobimetailic Complexes
(Percent growth inhibition after 4 da),s at 25:!:2C, Conc. in ppm. )
Compound Fusarium Aspergillus niger Helminthosporim
oxysporutn gramineutn
100 150 200 100 150 200 100 150 200
Pd(CsH7N3) 2C12
Pd(CsHsN3)2CI2Sn2(CH3)4
Pd(CsHsN3)2CI2Sn2(C6Hs)4
Pd(C5HsN3)2C 12S i2(CHa)4
Pd(CsHsN3)2CI2Si2(C6H5)4
Pd(CsHsN3)2CI2Ti2(CHs)4
Pd(CsHsN3) 2CI2Zr2(CsHs)4
Pt(CsH7N3)2CI2
Pt(CHsN3)ECI2Sn2(CH3)4
Pt(CsHsN3)2CI2Sn:(C6Hs)4
Pt(CsHsN3)2CI2Si2(CH3)4
Pt(CsHsN3)2CI2Si2(C6H5)4
Pt(CsHsN3)ECI2Ti2(CsHs)4
Pt(CsHN3)zCI2ZrE(CsHs)4
Standard (Bavistin)
30 33 37 31 33 39 33 40 42
41 47 50 43 48 53 46 53 56
63 70 73 65 70 76 70 78 85
38 39 42 39 43 47 44 49 53
58 62 65 59 63 66 63 73 80
34 37 40 40 41 43 35 37 49
33 36 43 35 39 41 37 38 51
31 32 35 32 33 35 35 39 43
43 46 53 46 49 56 48 52 57
66 73 77 68 70 78 72 79 83
38 42 43 41 42 49 45 47 54
61 70 72 62 69 72 69 73 78
35 36 40 38 39 40 39 43 50
33 37 41 37 39 43 38 44 47
88 100 100 90 100 100 87 100 100
Antifungal Activity
The antifungal activity has been evaluated against several fungi by the radial growth method38. The
compounds were directly mixed with the medium in 100, 150 and 200 ppm concentrations. Controls were
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also run and three replicates were used in each case. The linear growth of the fungus was obtained by
measuring the diameter of the fungal colony after four days. The amount of growth inhibition in each of the
replicates was calculated by equation (C-T) 100 C", where C is the diameter of the colony on the control
plate and T is the diameter of the fungal colony on the test plate.
Antibacterial Activity
The antibacterial activity was determined by the inhibition zone technique. All the compounds
were dissolved in methanol, paper discs of Whatman No. paper with a diameter of 5mm were soaked
in these solutions. These discs were placed on the appropriate medium previously seeded with
organisms in Petri discs and stored in an incubator at 30+1C. The inhibition zone thus formed around
each disc was measured in mm after 24 hours. Data ofthese activities are summarised in Tables IV and V.
Table V: Bactericidal Screening Data of Precursors and Their Heterobimetallic Complexes (Dimeter
of inhibition zone (mm) after 24 hours at 30-1C)
Compound Escherichia coli Klebsiella aerogenous Pseudomoztas cepacicola
500 1000 500 1000 500 1000
Pd(CsH7N3) 2C12
Pd(CsHsN3)2CI.Sn2(CH3)4
Pd(CsHN3)2CI2Snz(C6Hs)4
Pd(C HN3)2C 12S i2(CH3)4
Pd(CHsN3)zC12S i2(C6H5)4
Pd(CsHsN3)CITi2(CH)4
Pd(CsHsN3) 2CI2Zr2(CsHs)4
Pt(CsHvN)2CI2
Pt(CsHsNs)2CI2Sn2(CH3)4
Pt(CsH5N )2C 12SI12(C6H5)4
Pt(CsHsN3)2CI2Si2(CH3)4
Pt(CsHsN3)zCI2Si2(C6Hs)4
Pt(CsH5N )2C 1_Ti2(CHs)4
Pt(CsHsN3)zCI2Zr2(CsHs)4
Standard (Streptomycin)
3 4 2 4 2 3
6 10 7 9 7 8
9 11 10 11 11 13
4 5 5 7 4 6
7 8 9 10 9 11
4 5 6 7 5 6
4 6 6 6 6 7
2 3 2 4 3 4
7 8 6 7 5 8
11 12 8 10 9 11
5 6 4 5 4 6
9 10 7 9 7 10
4 4 3 5 4 5
4 5 5 6 4 5
17 18 13 14 15 16
The results reveal that the activity increases on complexation. The newly synthesized complexes
have indeed been found to be more active in inhibiting the growth of fungi and bacteria than the precursors
themselves. It may be postulated that these complexes might act as uncoupling agents of oxidation
39 posphorylation. The first uncoupling agent to be described, by Loomis and Lipmann was 2,4-dinitrophenol.
Today many different uncoupling agents are known. Most are lipid soluble substances containing an acidic
group and usually an aromatic ring. These agents allow electron transport to continue but prevent the
phosphorylation of ADP to ATP. They uncouple the energy-yielding fromthe energy conserving reactions.
Uncoupling agents function by breaking down a high-energy intermediate or state generated by electron
transport. They can promote the passage of H
+ ions through the cell membrane, which is normally
impermeable to them4. However, these agents are less effective for bacteria. The greater toxicity of metal
complexes than the precursors can also be explained on the basis of the chelation theory4’4. Chelation
reduces the polarity of metal ion mainly because of partial sharing of its positive charge with the
donor groups and possible r-electron-delocalisation over the whole chelation ring. This increases the
lipophilic character of the metal complex, which subsequently favours its permeation through the lipid layers
ofthe organism cell membrane, and the normal cell process being impaired.
Antifertility Activity
Male rats obtained from ICMR, New Delhi were used. Animals were housed in steel cages and
maintained under standard conditions (12 h light/12 h dark cycle; 25 +3C, 35 60% humidity), water and
food were given ad libitum. Proven fertile male rats were taken and divided into nine groups of six each. The
group A served as vehicle (olive oil) treated control. For groups B and F, starting material (PdCI2,
50mg/kg.b.wt.) suspended in olive oil was given for a period of 60 days. The animals of groups C, D and E
received same dose of its Pd(CsH7N3)2CI2, [Pd(CsHsN3)2Sn2(CH3)4]CI2 and [Pd(CsHsN3)2Sn2(C6Hs)4]CI2
respectively for the same period. The animals of group F received starting material that is PtCI2
50mg/kg.b.wt. suspended in olive oil. The animals of groups G,H and received Pt(CsH7N3)_,CI2,
[Pt(CsHsN3)2Sn2(CH3)4]CI2 and [Pt(CsHsN3)2Snz(C6Hs)4]CI2 respectively for the same period and dose. On
the day sixty first, these animals were autopsied and testes, epididymis, seminal vesicle and ventral prostate
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were removed, fat and connective tissue cleared off and kept at -20C until assayed for total protein, sialic
acid, cholestrol, fructose and glycogen by standard laboratory techniques.
Table VI: Alteration in the Body Weight and Weight of Reproductive Organs after Treatment with
Various Compounds
Group Treatment Body Weight (g)
Initial Final
A Control 180 +_15 201+_18
B PdCI2 175__.12 200+_10
C Pd(CsHTN3)2CI2 178+_20 185+_10
D Pd(CsHsNs)2CI2Sn2(CH3)4 185+_11 198+_12
E Pd(CsHsNs)2CI2Sn2(C6Hs)4 190+_15 215_10
F PtCI2 192+-18 220__12
G Pt(CsH7N3)2CI2 183_+20 218+-15
H Pt(CsHsN3)2CI2Sn2(CH3) 4 179+-15 199+-18
Pt(CsHN);CI2Sn2(CHs) 4 181+_12 205+_10e
a p< 0.05 b p< 0.001 c p NS
Groups B and F compared with group A
Groups D and E compared with group C
Groups H and compared with group G
Testes Epididy Seminal Ventral
mg/100 mis Vesicle Prostrate
gm b.wt. mg/100 mg/100 mg/100
gm b.wt. gm b.wt. gm b.wt.
1210+_90 480+_30 360+_20 255+_15
900+80 305+22
b 280_+12
b 210+-9b
805+-50 270+_15 240+-12 180+-12
705_+50 210+-18 215_+13b 140_+15b
700+70 200 _+19 175_+18 130+_10b
910_+70b 320+20
b 275_+14b 200_+18
720+80 260+- 14 230+ 19 170+20
650+70 208+15 200+22 143+25
b
630+-50 195+_18
b 170+-25
b 120_+22b
Group C compared with group B
Group G compared with group F
Table VII: Altered Sperm Dynamics and Fertility Test after Treatment with Precursors and Their
Complexes
Group Treatment Sperm motility (%) Sperm Density (Million/ml) Fertility Test
Cauda epididymis (%)
Testes Cauda
Epididymis
A Control 74+-3.0 3.5+-0.21 55+_4 100% (positive)
B PdCI2 60+_3.5b 2.0+-0.5
b 39+-2
b 80% (negative)
C Pd(CsHyN3)2CI2 50+-3.1 1.1+_0.5 35+_1.5 b 85% (negative)
D Pd(CsHsN3)2CI2Sn2(CH3)4 45+_2.5 1.0+_0.4 20+_1.8 b 90% (negative)
E Pd(CsHsN3)zCIzSn2(C6Hs)4 40+_3.2 0.8+_0.17 19+_0.9 b 95% (negative)
F PtCI2 622.8
b 2.7+_0.6 50+_5 b 75 % (negative)
G Pt(CsHTN3)2CIz 55_2.4 1.2+_0.4 b 40+_2 b 82% (negative)
H Pt(CHsN3)2CI2Sn2(CH3)4 49+_2.2 0.9+_0.2 b 18+_3 b 88% (negative)
Pt(CHN)zCI2Sn2(C6Hs) 41+_3.1 0.7+_0.10 15+_2 b 98% (negative)
See footnote ofTable VI
Fertility Test
The mating exposure tests of all the animals were performed from day 55
th to 60th. They were
cohabitated with proestrous females in the ratio 1:3. The vaginal plug and the presence of sperm in the
vaginal smear were checked for positive mating. The mated females were separated to note the implantation
sites on day 16
th of pregnancy through leprotomy.
Body and Organ Weight
No significant change was observed in the body weight after treatment with the compounds. A
significant reduction in the weight of testes, epididymis, seminal vesicle and ventral prostate was observed
after treatment with both the precursors and the compounds (Table VI).
Sperm Dynamics
Sperm motility in cauda epididymis and sperm density in testes and cauda epididymis were
significantly reduced after treatment with both the precursors and their compounds (Table VII).
BIOCHEMICAL PARAMETERS LEADING TO INFERTILITY
Total Protein
Treatment with both the precursors as well as their complexes resulted in a significant reduction in
the total protein contents of testes, epididymis, seminal vesicle and ventral prostate (Table VIII).
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Table VIII: Effects of Precursors and Their Complexes on Total Protein Contents of Various
Reproductive Organs of Male Rats
Group Treatment Total Protein (mg/gm)
Testes Epididymis Seminal Vesicle Ventral prostate
A Control 190+10 255+10 230+5 240+12
B PdCl2 150_.+5 190_+20 180_+4b 185+7
b
C Pd(CsH7N3)2CI2 130_+6 140_+10 130_+5 b 138_+8 b
D Pd(CsHsN3)ECIESnE(CH3)4 105_+10 b 102_+8 b 120_+7 b 114+-9
b
E Pd(CHN3) CIzSn2(C6H)4 100_+12 b 105_+10 b 105_+8 b 109_+10 b
F PtCI2 155_+4 200_+8 185_+9 190+8
b
G Pt(CsH7N3) 2C12 145_+8 150_+3 b 128_+7 b 150-+6
b
H Pt(CHN3)zCI2Snz(CH3)4 110_+4 b 104_+2 b 111_+6 b 128_+6 b
Pt(CHsN3) 2CIzSnz(C6H)4 103_+5 b 105-+5
b 101_+4 b 11-+10
b
See footnote ofTable VI
Sialic Acid
A significant reduction in sialic acid contents of testes, epididymis, seminal vesicle and ventral
prostate was observed after the treatment in all experimental groups (Table IX).
Table IX: Effects of Precursors and Their Complexes on Sialic Acid of Various Reproductive Organs
of Male Rats
Group Treatment Sialic Acid (mg/gm)
Testes Epididymis Seminal Vesicle Ventral prostate
A Control 8.5_+0.9 7.3_+0.8 7.9_+0.6 8.1+_0.8
B PdClz 6.1-+0.7 5.3-+0.9 6.1-+0.2 6.3-+0.2
b
C Pd(CsH7N3)2CI2 4.6_+0.4 b 4.4_+0.5b 4.1-+0.1
b 5.0_+0.1
D Pd(CsHN3)zCIzSnz(CH3)4 4.3_+0.2 b 3.8_+0.6 b 3.4_+0.3 b 4.1+_0.2 b
E Pd(CsHN3) 2ClzSn2(C6Hs)4 3.9-!-0.2
b 3.7-+0.4
b 3.1-+0.2
b 4.0_+0.1 b
F PtCI2 5.9_+0.5 b 5.7_+0.4 b 5.8+0.3
b 6.2_+0.1 b
G Pt(CH7N3) C12 3.8_+0.1 b 4.0_+0.3 b 3.8_+0.5 b 4.9_+0.1 b
H Pt(CsHN3)zCIzSnz(CH3)4 3.5+0.2
b 3.6-+0.2
b 3.2_+0.1 b 4.2_+0.3 b
Pt(CHsN3) zcI2Sn2(C6H)4 3.0-+0.3
b 3.1_+6.1 b 3.0_+0.2 b 3.4_+0.5 b
See footnote ofTable VI
Cholesterol
Cholesterol contents of testes were decreased significantly in all experimental groups (Table X).
Fructose
A significant decrease in the seminal vesicular fructose was noticed in all experimental
groups (Table IX).
Table X: Effects of Precursors and Their Complexes on Tissue Cholesterol Glycogen and Fructose
Group Treatment Fructose (mg/gm) Cholesterol Glycogen (mg/gm)
Seminal Vesicle (mg/gm) Testes Testes
A Control 450-+30 8.2-+0.6 5.0_+0.3
B PdClz 360_+10b 6.2_+0.5 b 3.7_+0.2 b
C Pd(CsH7N3)2CI2 290 +15
b 5.1_+0.1 b 2.9_+0.2 b
D Pd(CHNa)zCIzSnz(CHa)4 280_+10 b 4.9_+0.2 b 2.5_+0.3 b
E Pd(CsHN) 2CIzSn2(C6H)4 260+12
b 4.4_+0.3 b 2.0_+0.1 b
F PtClz 375-+15
b 6.7_+0.2 b 3.2_+0.1 b
G Pt(CH7N) 2C12 300_+5 b 3.8_+0.5 2.1_+0.2 b
H Pt(CHsN3)2CIzSnz(CHa)4 275_+12 b 3.5_+0.3 b 2.2_+0.2 b
Pt(CHsN.) 2CIzSnz(C6Hs)4 220_+20 b 3.1_+0.2 b 2.4_+0.1 b
Cf. Table VI
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Glycogen
Testicular glycogen was depleted significantly in all experimental groups (Table IX).
Present study showed that oral administration of PdClz, PtCI2, precursors and their complexes
resulted in the reduction Of weights of testes, epididymis, seminal vesicle and ventral prostate. The weight,
size and secretory activities of sex accessories are closely regulated by androgen levels43. Reduction in sperm
density and motility in cauda epididymis is of importance with regards to fertilization44. Significant reduction
in the sperm motility and sperm density was observed in treated animals. This may be due to inhibitory effect
of these compounds on the enzyme oxidative phosphorylation45. In our study various androgen dependent
parameters that is total protein, sialic acid, fructose, cholestrol and glycogen revealed a significant decrease
indicating that administration of these compunds resulted in the fall of circulating androgen46’47. It is inferred
that compounds of Pd and Pt are found to be more effective than the starting materials in inhibiting the
fertility.
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